Meeting
2022 ASCO Annual Meeting
DNA damage repair (DDR) germline mutations (GMs) in pancreatic ductal adenocarcinoma (PDAC): A mono-institutional retrospective study.
Authors
Maria Bensi
Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli–IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
Maria Bensi , Angelo Minucci , Marta Ribelli , Brunella Di Stefano , Viria Beccia , Alexia Spring , Paola Concolino , Enrico Gurreri , Federico Monaca , Diletta Barone , Marta Chiaravalli , Maria Grazia Maratta , Andrea Urbani , Cinzia Bagalà , Giampaolo Tortora , Lisa Salvatore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10587)
DOI
10.1200/JCO.2022.40.16_suppl.10587
Abstract #
10587
Poster Bd #
462
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Retrospective study of survival outcomes in patients with hereditary pathogenic and variants of unknown significance mutations in pancreatic adenocarcinoma.
First Author: Ching Ying Lin
Poster
2022 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA alterations in mCRPC patients with germline pathogenic mutations.
First Author: Malcolm Light
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic germline mutations prevalence in Saudi patients with pancreatic ductal adenocarcinoma.
First Author: Mohammed Ahmed Algarni
Poster
2021 Gastrointestinal Cancers Symposium
Genomic characterization of ATM alterations in advanced pancreatic ductal adenocarcinoma (PDAC).
First Author: Sheron Perera